Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Adam Koppel Insider Profile
11 Followers
Adam Koppel, EVP, Strategy and Bus. Dev at Biogen, holds 65.69M shares in Cerevel Therapeutics Holdings (Ticker: CERE), holds 4.03M shares in Solid Biosciences (Ticker: SLDB), holds 487.50K shares in BCLS Acquisition (Ticker: BLSA).
Profitable Transactions
5 out of 6 Profitable Transactions
Average Return
+92.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Adam Koppel holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Oct 29, 2020 - Oct 29, 2021
Return:+306.50%
The most profitable trade made by Adam Koppel
Adam Koppel's Trading History
Biogen
Jun 07, 2016
EVP, Strategy and Bus. Dev
Uninformative Sell
160.95K
$665.38K
Dicerna Pharma
Dec 06, 2019
―
Informative Sell
37.02M
$117.85M
Solid Biosciences
Jan 12, 2024
Director, Ten Percent Owner
Uninformative Buy
5.00M
$38.89M
Aptinyx
Jan 16, 2020
―
Informative Buy
10.00M
$533.61K
BCLS Acquisition
Oct 26, 2020
―
Uninformative Buy
4.88M
$4.89M
Cerevel Therapeutics Holdings
Jun 07, 2024
Director, Ten Percent Owner
Uninformative Buy
―
$2.79B
Foghorn Therapeutics
―
Director
―
―
PTC Therapeutics
Jun 27, 2013
Director
Informative Buy
18.75M
$79.73M
Trevena
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Adam Koppel's performance on stock
You May Also Like
Adam Koppel insider profile FAQ
What is the percentage of profitable transactions made by Adam Koppel?
The percentage of profitable transactions made by Adam Koppel is 83%.
What is the average return per transaction made by Adam Koppel?
The average return per transaction made by Adam Koppel is 92.30%.
What stocks does Adam Koppel hold?
Adam Koppel holds: BIIB, DRNA, SLDB, APTX, BLSA, CERE, FHTX, PTCT, TRVN stocks.
What was Adam Koppel’s latest transaction?
Adam Koppel latest transaction was an Uninformative Buy of ―.
What was Adam Koppel's most profitable transaction?
Adam Koppel’s most profitable transaction was an Informative Buy of CERE stock on October 29, 2020. The return on the trade was 306.50%.
What is Adam Koppel's role in Biogen?
Adam Koppel's role in Biogen is EVP, Strategy and Bus. Dev.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.